• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer.肺叶下切除术:早期肺癌的新护理标准。
Cancers (Basel). 2023 May 25;15(11):2914. doi: 10.3390/cancers15112914.
2
Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer.楔形切除术、肺段切除术和肺叶切除术:基于手术切除范围的≤2 cm IA期非小细胞肺癌的肿瘤学结局
J Thorac Dis. 2024 Mar 29;16(3):1875-1884. doi: 10.21037/jtd-23-1693. Epub 2024 Mar 15.
3
Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?晚期非小细胞肺癌的手术治疗:肺叶切除术还是肺段以下切除术?
Transl Lung Cancer Res. 2021 Mar;10(3):1408-1423. doi: 10.21037/tlcr-21-39.
4
Oncological Outcomes of Lobar Resection, Segmentectomy, and Wedge Resection for T1a Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.T1a 期非小细胞肺癌行肺叶切除术、节段切除术和楔形切除术的肿瘤学结果:系统评价和荟萃分析。
Semin Thorac Cardiovasc Surg. 2020;32(3):582-590. doi: 10.1053/j.semtcvs.2019.08.004. Epub 2019 Aug 9.
5
Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.IA期老年非小细胞肺癌患者(≥70岁)肺叶切除术与肺段切除术的比较:一项基于人群的倾向评分匹配研究。
Front Oncol. 2021 May 7;11:610638. doi: 10.3389/fonc.2021.610638. eCollection 2021.
6
Lung Segmentectomy in NSCLC Surgery.非小细胞肺癌手术中的肺段切除术
Life (Basel). 2023 May 30;13(6):1284. doi: 10.3390/life13061284.
7
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.I 期非小细胞肺癌:波兰国家肺癌登记处肺叶切除术与亚肺叶切除术的长期结果。
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):363-369. doi: 10.1093/ejcts/ezx092.
8
Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers--a Surveillance Epidemiology End Results database analysis.亚肺叶切除术与肺叶切除术治疗小(≤2cm)非小细胞肺癌的术后转归的时间趋势:一项监测、流行病学和最终结果数据库分析。
J Surg Res. 2013 Jul;183(1):27-32. doi: 10.1016/j.jss.2012.11.052. Epub 2012 Dec 20.
9
Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis.cT1a/b cN0 cM0 期非小细胞肺癌楔形切除术与肺叶切除术的真实世界生存结局:一项单中心回顾性分析
Front Oncol. 2023 Aug 17;13:1226429. doi: 10.3389/fonc.2023.1226429. eCollection 2023.
10
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.

引用本文的文献

1
Exploring the impact of surgical treatment for lung cancer in patients with Airway Obstruction from a Lung Cancer Screening Program.探索肺癌筛查项目中气道阻塞患者接受肺癌手术治疗的影响。
PLoS One. 2025 May 8;20(5):e0320704. doi: 10.1371/journal.pone.0320704. eCollection 2025.
2
Integrative analysis of high-dimensional RCT and RWD subject to censoring and hidden confounding.对受删失和隐藏混杂因素影响的高维随机对照试验和真实世界数据进行综合分析。
Lifetime Data Anal. 2025 Jul;31(3):473-497. doi: 10.1007/s10985-025-09654-1. Epub 2025 Apr 29.
3
Outcome of anatomical versus non-anatomical lung resection for necrotizing pneumonia in children.儿童坏死性肺炎行解剖性与非解剖性肺切除的结果
World J Pediatr Surg. 2024 Dec 26;7(4):e000943. doi: 10.1136/wjps-2024-000943. eCollection 2024.
4
Performing High-Quality Sublobar Resections: Key Differences Between Wedge Resection and Segmentectomy.实施高质量亚肺叶切除术:楔形切除术与肺段切除术的关键差异
Cancers (Basel). 2024 Nov 27;16(23):3981. doi: 10.3390/cancers16233981.
5
A conundrum of honeycombing: challenges in tumor size estimation in patients with honeycombing in the lung.蜂窝状结构的难题:肺部存在蜂窝状结构的患者肿瘤大小估计面临的挑战
J Thorac Dis. 2024 May 31;16(5):2709-2712. doi: 10.21037/jtd-24-437. Epub 2024 May 27.
6
N1-positive non-small cell lung cancer: surgeons' perspective before undertaking a major resection.N1 阳性非小细胞肺癌:外科医生在进行大手术切除前的观点。
Indian J Thorac Cardiovasc Surg. 2024 May;40(3):353-356. doi: 10.1007/s12055-024-01724-7. Epub 2024 Mar 27.

本文引用的文献

1
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.肺段或亚肺叶切除术治疗外周型ⅠA 期非小细胞肺癌。
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
2
Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I non-small-cell lung cancer.肺段切除术与楔形切除术治疗Ⅰ期非小细胞肺癌的可行性和有效性。
Eur J Cardiothorac Surg. 2023 Mar 1;63(3). doi: 10.1093/ejcts/ezad018.
3
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
4
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.新辅助纳武利尤单抗联合化疗治疗可切除肺癌。
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
5
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.辅助阿特珠单抗治疗辅助化疗后切除的 IB-IIIA 期非小细胞肺癌(IMpower010):一项随机、多中心、开放标签、III 期临床试验。
Lancet. 2021 Oct 9;398(10308):1344-1357. doi: 10.1016/S0140-6736(21)02098-5. Epub 2021 Sep 20.
6
Complex segmentectomy is not a complex procedure relative to simple segmentectomy.复杂的节段切除术与简单的节段切除术相比并不复杂。
Eur J Cardiothorac Surg. 2021 Dec 27;61(1):100-107. doi: 10.1093/ejcts/ezab367.
7
Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.胸腔镜楔形切除术与节段切除术治疗 cT1N0 肺腺癌。
Ann Surg Oncol. 2021 Dec;28(13):8398-8411. doi: 10.1245/s10434-021-10213-9. Epub 2021 Jun 18.
8
Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.80 岁以上早期非小细胞肺癌患者楔形切除术与肺叶切除术/肺段切除术的生存比较:JACS1303。
Ann Surg Oncol. 2021 Nov;28(12):7219-7227. doi: 10.1245/s10434-021-09835-w. Epub 2021 Apr 26.
9
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
10
Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.楔形切除术与肺段切除术治疗不适合肺叶切除术的 I 期非小细胞肺癌患者。
Jpn J Clin Oncol. 2019 Dec 27;49(12):1134-1142. doi: 10.1093/jjco/hyz122.

肺叶下切除术:早期肺癌的新护理标准。

Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer.

作者信息

Lee Benjamin E, Altorki Nasser

机构信息

Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Suite M404, Weill Cornell Medicine of Cornell University, 525 East 68th Street, New York, NY 10065, USA.

出版信息

Cancers (Basel). 2023 May 25;15(11):2914. doi: 10.3390/cancers15112914.

DOI:10.3390/cancers15112914
PMID:37296877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10251869/
Abstract

The Lung Cancer Study Group previously established lobectomy as the standard of care for treatment of clinical T1N0 NSCLC. Advances in imaging technology and refinements in staging have prompted a re-investigation to determine the non-inferiority of sub-lobar resections to lobectomies. Two recent randomized studies, JCOG 0802 and CALGB 140503, are reviewed here in the context of LCSG 0821. The studies confirm non-inferiority for sub-lobar resection (wedge or segmentectomy) compared to lobectomy for peripheral T1N0 NSCLC less than or equal to 2 cm. Sub-lobar resection should therefore be considered the new standard of care in this sub-set of patients with NSCLC.

摘要

肺癌研究组先前已将肺叶切除术确立为临床T1N0非小细胞肺癌治疗的护理标准。成像技术的进步和分期的细化促使人们重新进行调查,以确定肺叶以下切除术相对于肺叶切除术的非劣效性。本文在LCSG 0821的背景下对两项近期的随机研究JCOG 0802和CALGB 140503进行了综述。这些研究证实,对于直径小于或等于2 cm的外周T1N0非小细胞肺癌,肺叶以下切除术(楔形切除术或肺段切除术)相对于肺叶切除术具有非劣效性。因此,对于这一非小细胞肺癌患者亚组,肺叶以下切除术应被视为新的护理标准。